Prolyl oligopeptidase-like deficient Trypanosoma evansi parasites are associated with reduced interleukin-10 concentrations in vivo and in vitro

Authors:
Richard T. Kangethe, Eva M. Winger, Tirumala B.K. Settypalli, Viskam Wijewardana, Johanna Slaets, Theresa H. T. Coetzer, Adama Diallo
In:
Source:
Publication Date: (2017)
Issue: :
Research Area:
Parasitology
Cells used in publication:
Trypanosoma evansi
Species: unicellular
Tissue Origin: blood
Platform:
4D-Nucleofector® X-Unit
Experiment

In order to transfect T. evansi RoTat 1.2 parasites, it was necessary to define the conditions required for the successful integration of recombinant plasmids in trypanosomes when using the 4D-Nucleofector™ system (Lonza, Levallois-Perret, France). Following recommendations from the manufacturer, an optimization experiment that combines 23 different Nucleofector™ programs with 5 different solutions (P1–P5) for a total of 115 reactions was set up.

Briefly, for each reaction, a pellet of 106 parasites was resuspended in 20 µL of solutions P1–P5 along with 1 µg of NotI-linearized pLEW20-green fluorescent protein (GFP), a plasmid that was previously used for GFP expression in T. brucei (Wirtz et al. Reference Wirtz, Leal, Ochatt and Cross1999; Coustou et al. Reference Coustou, Guegan, Plazolles and Baltz2010), and transfected using one of the programs recommended by the manufacturer. Transfected parasites were first cultured for 24 h in the supplemented IMDM medium (Hirumi and Hirumi, Reference Hirumi and Hirumi1989) before addition of 2 µg mL-1 of phleomycin for the selection of viable clones. Successful clones were analysed for GFP expression using flow cytometry. The successful combination of transfection program and P1–P5 solutions from the Nucleofector™ kit was established for gene knock-out experiments.

[...]

The matrix of 115 conditions recommended by the manufacturer yielded two combinations that produced viable clones: the program EF100 combined with solution P3 and the program DI100 with solution P5. Following the transfection, the potential recombinants were analysed for GFP fluorescence using flow cytometry (Supplementary Fig. S1). The combination of Program DI100 with solution P5 produced a higher number of clones when compared with program EF100 combined with solution P3 (results not shown) and was therefore chosen for future experiments.

Abstract

The protozoan parasite Trypanosoma evansi is responsible for causing Surra in a variety of mammalian hosts over a wide geographical area. In the absence of an effective vaccine and increasing resistance to current chemotherapeutic agents, peptidases from the S9 prolyl oligopeptidase family have been identified as potential drug and vaccine targets. In order to understand the function of these peptidases during infection, three null mutant clones for prolyl oligopeptidase (?pop), prolyl oligopeptidase-like (?pop-like) and oligopeptidase B (?opb) were generated in T. evansi RoTat 1.2 parasites and used for infection of mice. Mice inoculated with T. evansi ?pop-like mutants were able to survive longer than other groups of mice inoculated with ?pop, ?opb mutants or wild-type parasites. The regression analysis of plasma from mice-infected over time using ?pop-like mutants showed stable levels of interleukin-10 (IL-10) (non-significant slope, P = 0·171) and declining IL-1b levels (negative slope, P = 0·04) when compared with the wild-type control that demonstrated increasing levels of IL-10 and IL-1b (P < 0·01 for both). Further analysis using mouse spleen cells in an in vitro 24 h incubation assay revealed that the percentage of IL-10 producing CD3 positive cells display significantly lower values when incubated with ?pop-like parasites than the wild-type clone (P = 0·002). These results suggest that prolyl oligopeptidase-like peptidase may play a role in immune responses during T. evansi infections by affecting interleukin concentrations in the host.